Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 88, Issue 4, 1999, Pages 378-382

  Ehrenkrantz, David ^a,b   Silverman, Jeremy M ^a,b   Smith, Christopher J ^a,b   Birstein, Sandra ^a,b   Marin, Deborah ^a,b   Mohs, Richard C ^a,b   Davis, Kenneth L ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Age at onset; Dementia; Family history; Genetic imprinting; Mitochondrial genes

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE TRANSMISSION; FATHER; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTHER; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FATHERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MOTHERS; RISK;

EID: 0033588280     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990820)88:4<378::AID-AJMG15>3.0.CO;2-8     Document Type: Article

References (26)

1. Breitner JCS, Folstein MF. 1984. Familial Alzheimer's disease: a prevalent disorder with specific clinical features. Psychol Med 14:63-80.
2. Davis JN, Parker-WD J. 1998. Evidence that two reports of mtDNA cytochrome c oxidase "mutations" in Alzheimer's disease are based on nDNA pseudogenes of recent evolutionary origin. Biochem Biophys Res Commun 244:877-883.
3. Davis RE, Miller S, Herrnstadt C, et al. 1997. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer's disease. Proc Natl Acad Sci 94:4526-4531.
4. Duara R, Lopez-Alberola RF, Barker WW, et al. 1993. A comparison of familial and sporadic Alzheimer's disease. Neurology 43:1377-1384.
5. Edland SD, Silverman JM, Peskind ER, Tsuang D, Wijsman E, Morris JC. 1996. Increased risk of dementia in mothers of Alzheimer's disease cases: Evidence for maternal inheritance. Neurology 47:254-256.
6. Evans DA, Funkenstein HH, Albert MS, et al. 1989. Prevalence of Alzheimer's disease in a community population of older persons, higher than previously reported. [See comments] J Am Med Assoc 262:2551-2556.
7. Farrer LA, Cupples LA, Wolf PA, Growdon JH. 1991. Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting? Arch Neurol 48:599-604.
8. Fratiglioni L, Viitanen M, van Strauss E, Tontodonati V, Herlitz A, Winblad B. 1997. Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungshomen Project, Stockholm. Neurology 48:132-138.
9. Hirano M, Shtilbans A, Mayeux R, et al. 1997. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. Proc Natl Acad Sci USA 94:14894-14899.
10. Hixon JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 31:545-548.
11. Kawas C, Segal J, Stewart WF, Corrado M, Thai L. 1994. A validation study of the Dementia Questionnaire. Arch Neurol 51:901-906.
12. King TM, Beaty TH, Liang K-Y. 1996. Comparison of methods for survival analysis of dependent data. Genet Epidemiol 13:139-158.
13. Lautenschlager NT, Cupples LA, Rao VS, et al. 1996. Risk of dementia of Alzheimer's disease patients in the MIRAGE study: what is in store for the oldest old? Neurology 46:641-650.
14. Lee ET. 1992. Statistical methods for survival data analysis. New York: John Wiley & Sons, Inc.
15. Li G, Aryan M, Silverman JM, et al. 1997. A validity study of family history assessment of primary progressive dementia. Arch Neurol 54:634-640.
16. Li G, Silverman JM, Altstiel LD, et al. 1996. Apolipoprotein ε4 allele and familial risk in Alzheimer's disease. Genet Epidemiol 13:285-298.
17. Li G, Silverman JM, Smith CJ, et al. 1995. Age at onset and familial risk in Alzheimer's disease. Am J Psychiatry 152:424-430.
18. Lin DY. 1993. MULCOX2: a general computer program for the Cox regression analysis of multivariate failure time data. Computer Meth Prog Biomed 40:279-293.
19. Mattson MP. 1997. Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease. Trends Neurosci 20:373-375.
20. Payami H, Hoffbuhr K. 1993. Lack of evidence for maternal effect in familial Alzheimer's disease. Genet Epidemiol 10:461-464.
21. Reik W. 1996. The Wellcome Prize Lecture. Genetic imprinting: the battle of the sexes rages on. Exp Physiol 81:161-172.
22. Saunders AM, Schmader K, Breitner JCS, et al. 1993. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming disease. Lancet 342:710-711.
23. Silverman JM, Breitner JCS, Mohs RC, Davis KL. 1986. Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry 143:1279-1282.
24. Silverman JM, Keefe RSE, Mohs RC, Davis KL. 1990. A study of the reliability of the family history method in genetic studies of Alzheimer's disease. Alzheimer's Disease Assoc Disorders 3:218-223.
25. Silverman JM, Li G, Zaccario ML, et al. 1994. Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry 51:577-586.
26. Wallace DC, Stugard C, Murdock D, Schurr T, Brown MD. 1997. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. Proc Natl Acad Sci USA 94:14900-14905.